Clinical Trial Update: "Can Soluble-CD163 Discriminate Between Healthy and Unhealthy Obese Individuals?"

View source ↗

Summary

Completed clinical trial evaluating whether soluble-CD163 can discriminate between healthy and unhealthy obese individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation
• Insulin Resistance
• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Aarhus | Conditions: Obesity, Insulin Resistance | Status: COMPLETED